Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 3 minute read Chemical Industry News Tata Chemicals Q3FY25 earnings drop amid soda ash pricing pressures and global market challenges Tata Chemicals Limited reported a decline in earnings for the third quarter of fiscal year 2025 (Q3FY25), with… byPallavi MadhirajuFebruary 4, 2025